Alice Drumheller has over twenty years’ experience in the clinical operations area with the focus on executing clinical trials and works as VP of Clinical Operations at Salubris Bio. Previously, Alice was Senior Director of Clinical Operations at MacroGenics where she executed the company’s clinical strategy. Prior to MacroGenics, Alice was part of the team at Amgen/Micomet where she contributed to the approval of BLINCYTO®. Alice has held positions of increasing responsibility at large pharmaceutical companies, start-up companies and clinical research organizations, including Sensei Bio, Nabi Biopharmaceuticals, Bristol-Myers Squibb, Kendle (now Syneos), British Biotech and Henri Beaufour Institute (a subsidiary of Ipsen). Alice holds a BS in Public and Community Health from Southern Connecticut State University in New Haven, CT.
